|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
SCIDIR_ocn884495567 |
003 |
OCoLC |
005 |
20231120111705.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140724s1994 ne a ob 101 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCO
|d N$T
|d E7B
|d YDXCP
|d EBLCP
|d OCLCQ
|d OCL
|d STF
|d OCLCQ
|d VLY
|d COM
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 896795505
|a 1162100464
|
020 |
|
|
|a 9781483161570
|q (electronic bk.)
|
020 |
|
|
|a 1483161579
|q (electronic bk.)
|
020 |
|
|
|z 9780444820273
|
035 |
|
|
|a (OCoLC)884495567
|z (OCoLC)896795505
|z (OCoLC)1162100464
|
050 |
|
4 |
|a RS199.5
|b .I58 1993eb
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.6
|2 23
|
111 |
2 |
|
|a International Symposium on Recent Advances in Drug Delivery Systems
|n (6th :
|d 1993 :
|c Salt Lake City, Utah)
|
245 |
1 |
0 |
|a Advances in drug delivery systems, 6 :
|b proceedings of the Sixth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, U.S.A., February 21-24, 1993 /
|c edited by James M. Anderson [and others].
|
264 |
|
1 |
|a Amsterdam ;
|a London :
|b Elsevier,
|c 1994.
|
300 |
|
|
|a 1 online resource (xii, 360 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a "This set of papers has been published as a special issue of Journal of controlled release, Vol. 28, issues 1-3."
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Advances in Drug Delivery Systems, 6; Copyright Page; Preface; Table of Contents; Part I: Novel Drug Delivery Systems; Chapter 1. Biologically engineered microstructures: controlled release applications; Introduction; Microstructure geometry and controlled release; Flat porus media; Spheres; Rigid hollow microcylinders; Controlled release from microcylinders; Antifouling applications; Methods for environmental exposure testing; Controlled release of proteins from lipid microcylinders; Summary and Conclusion; Acknowledgements; References.
|
505 |
8 |
|
|a Chapter 2. New approaches to targeting bioactive compoundsIntroduction; Fatty acylated antibodies; Effect of artificial fatty acylation on protein binding and uptake; Suppression of virus reproduction with fatty acylated antiviral antibodies; Therapeutic efficiency of fatty acylated antiviral antibodies; Antisense oligonucleotides combined with a lipid moiety; DNA interpolyelectrolyte complexes as a tool for gene delivery into a cell; Respecrins: a new class of immunotoxins; Acknowledgments; References; Chapter 3. Mucosal delivery of macromolecules; Introduction; Experimental; Materials.
|
505 |
8 |
|
|a Buccal solution preparationBuccal device fabrication; In vivo experiments; Intravenous bolus experiments; Buccal solution experiments; Buccal device experiments; Results and Discussion; Conclusions; References; Chapter 4. Targeted delivery of diagnostic agents by surface-modified liposomes; Introduction; The mechanism of protective action of PEG on liposomes; Co-immobilization of PEG and antibody on the liposome surface: long-circulating immunoliposome accumulation in myocardial infarct.
|
505 |
8 |
|
|a Surface modification of liposomes with chelating groups for delivery of imaging agents: lymph node visualization and modification of MRI contrast properties of Gd-liposomesAcknowledgement; References; Chapter 5. Influencing factors on in vitro micelle stability of adriamycin-block copolymer conjugates; Introduction; Experimental part; Materials; Preparation of drug-block copolymer conjugates; HPLC measurements; Results and Discussion; Conclusions; Acknowledgements; References; Chapter 6. SK & F 110679: comparison of absorption following oral or respiratory administration; Introduction.
|
505 |
8 |
|
|a Materials and MethodsChemicals; Intestinal transport of SK & F 110679; Intraduodenal administration of SK & F 110679; Intratracheal dosing and measurement of plasma growth hormone levels in rats; Intratracheal and intravenous dosing of SK & F 110679 in dogs; Measurement of plasma levels of SK & F 110679; Data analysis; Transport of [3H]SK & F 110679 across rabbit intestinal mucosa in vitro; Absorption of SK & F 110679 in the rat; Plasma concentrations of SK & F 110679 following intravenous, intraduodenal or intratracheal administration in dogs; Discussion; Acknowledgements; References.
|
520 |
|
|
|a Advances in Drug Delivery Systems, 6.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Drug delivery systems
|v Congresses.
|
650 |
|
6 |
|a Syst�emes d'administration de m�edicaments
|0 (CaQQLa)000260397
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug delivery systems
|2 fast
|0 (OCoLC)fst00898667
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Anderson, James M.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|a International Symposium on Recent Advances in Drug Delivery Systems (6th : 1993 : Salt Lake City, Utah).
|t Advances in drug delivery systems, 6
|z 0444820272
|w (OCoLC)30735620
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444820273
|z Texto completo
|